Lexicon Pharmaceuticals
LXRX
#6055
Rank
NZ$1.76 B
Marketcap
NZ$3.97
Share price
-4.51%
Change (1 day)
340.37%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$0.12 M-98.97%
2025NZ$12.43 M-38.43%
2024NZ$20.19 M111.04%
2023NZ$9.57 M315.88%
2022NZ$2.3 M-91.22%
2021NZ$26.2 M1.63%
2020NZ$25.78 M21.18%
2019NZ$21.27 M-6.95%
2018NZ$22.86 M-27.5%
2017NZ$31.53 M18.35%
2016NZ$26.64 M59.83%
2015NZ$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
NZ$4.97 MNZ$57.73 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$13.38 MNZ$25.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$3.28 MNZ$47.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$0.05 MNZ$9.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.85 MNZ$10.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.87 MNZ$8.77 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/ANZ$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.45 MNZ$17.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/ANZ$0.02 M๐Ÿ‡บ๐Ÿ‡ธ USA